What is CKD?
🩺 KDIGO Definition
CKD is defined as abnormal kidney structure or function persisting for more than 3 months, with implications for health. Diagnosis requires eGFR <60 mL/min/1.73m² OR albumin:creatinine ratio (ACR) >3 mg/mmol (equivalently >30 mg/g), or other markers of kidney damage.

The 3-month criterion differentiates CKD from acute kidney injury (AKI). Many patients with eGFR 60–89 may have CKD if albuminuria or structural abnormalities are present. CKD is often silent — most patients are asymptomatic until G4–G5.

CKD Staging — KDIGO GFR Categories
G1
eGFR ≥90
Normal / High — with kidney damage markers
G2
eGFR 60–89
Mildly decreased
G3a
eGFR 45–59
Mild-moderate decrease
G3b
eGFR 30–44
Moderate-severe
G4
eGFR 15–29
Severely decreased
G5
eGFR <15
Kidney failure — RRT
🔬 Albuminuria Categories (A1–A3)
CategoryACR (mg/mmol)ACR (mg/g)Description
A1<3<30Normal to mildly increased
A23–3030–300Moderately increased (microalbuminuria)
A3>30>300Severely increased (macroalbuminuria/nephrotic range)

Combined GFR + albuminuria staging drives risk stratification and monitoring frequency. Higher ACR at any eGFR = worse prognosis and faster progression.

Causes of CKD
📊 Common Causes (Global & GCC)
  • Diabetic nephropathy — #1 worldwide (~40%); dominant in GCC due to very high T2DM prevalence
  • Hypertensive nephrosclerosis — #2 (~25%); closely linked to DM in GCC
  • Glomerulonephritis — IgA, FSGS, lupus nephritis; more prominent in younger GCC patients
  • Polycystic kidney disease (ADPKD) — genetic; family screening essential
  • Obstructive uropathy — stones, BPH, congenital; common cause of preventable CKD
  • Recurrent AKI — contributes to CKD progression; occupational heat exposure in GCC migrant workers
  • Genetic/hereditary — Alport syndrome, FSGS in consanguineous GCC families
📉 ESRD Trajectory

GFR declines at an average of 1–2 mL/min/year in most patients. Diabetic nephropathy can accelerate this to 4–6 mL/min/year if poorly controlled.

Kidney survival depends on: degree of proteinuria (ACR >300 = fastest decline), BP control, glycaemic control (HbA1c <53 mmol/mol / 7%), use of RAAS blockade, smoking cessation, and SGLT-2 inhibitors.

SGLT-2 inhibitors (empagliflozin, dapagliflozin) — KDIGO 2024 recommends in CKD G1–G3b with ACR >20 mg/mmol, regardless of diabetes status.
GCC CKD Burden
🌍 Epidemiology in the Region
  • UAE: diabetes prevalence ~19% of adult population — one of the highest globally → high ESRD incidence
  • Saudi Arabia: some regional studies report up to 24% CKD prevalence; over 18,000 patients on dialysis (largest dialysis population in the region)
  • Qatar, Kuwait, Bahrain: rapidly growing dialysis populations
  • Oman: improving CKD detection programmes via primary care
  • Dialysis demand growing at ~6–8% per year in GCC countries
👩‍⚕️ CKD Nurse Specialist Role
  • Patient and family education — CKD understanding, diet, medicines
  • Structured monitoring — bloods, BP, weight, urine
  • Complication recognition and escalation
  • RRT modality education — haemodialysis, peritoneal dialysis, transplant, conservative care
  • Access planning — AV fistula/PD catheter referral
  • Psychosocial support and advance care planning
  • Coordination with renal dietitian, pharmacist, vascular surgery, transplant team
Pre-Dialysis Nursing Checklist
Key Actions — Save with localStorage
Key Monitoring Parameters
🔬 Blood Tests
  • eGFR (CKD-EPI) — trend over time is more important than single value
  • Urine ACR / PCR — first-morning sample; repeat if abnormal
  • Haemoglobin — anaemia of CKD; target 100–120 g/L on EPO
  • Iron stores — ferritin >200 µg/L, TSAT >20% before/during EPO
  • Potassium — hyperkalaemia risk increases at G4+; target 3.5–5.0 mmol/L
  • Phosphate — rises in G4/G5; target 0.8–1.5 mmol/L
  • Corrected calcium — hypocalcaemia in renal bone disease
  • PTH — secondary hyperparathyroidism marker; target 2–9x upper limit
  • Bicarbonate — metabolic acidosis; target >22 mmol/L
  • Vitamin D (25-OH) — replete if <50 nmol/L
  • HbA1c — glycaemic control in diabetic CKD; note: less reliable at eGFR <30
  • Uric acid — hyperuricaemia in CKD; treat if symptomatic or high risk
🫀 Clinical Monitoring
  • Blood pressure — target <130/80 mmHg (all CKD); <120/80 if diabetic CKD with proteinuria per SPRINT/ACCORD guidance
  • Weight & fluid status — oedema, orthopnoea, JVP — fluid overload in G4+
  • Urine output — oliguria (<400 mL/day) signals advancing ESKD or AKI
  • Symptom review — fatigue, itch, restless legs, nausea, dyspnoea
  • BP technique — clinic vs home monitoring vs ABPM (ambulatory)
Home BP Monitoring: Recommend morning + evening, 2 readings each, for 7 days. Discard day 1. Average remainder. ABPM preferred in white-coat hypertension.
Monitoring Frequency by CKD Stage
CKD StageeGFR & ACRBPHaem / IronElectrolytes / MineralsUrine ACR
G1–G2 Annual Every visit / monthly if uncontrolled Annual if no anaemia Annual Annual (3-monthly if ACR >3)
G3a–G3b Every 6 months Monthly until stable 6-monthly 6-monthly (K+, PO₄, Ca, PTH, bicarb) 6-monthly
G4 Every 3–4 months Monthly 3-monthly 3-monthly (add Vit D annually) 3-monthly
G5 (pre-dialysis) Monthly Weekly if unstable / monthly if stable Monthly (EPO dose adjustment) Monthly — all parameters Monthly

Frequency should increase if CKD is rapidly progressive (fall >5 mL/min in 12 months), acute illness, new medication change, or following AKI episode.

Interactive CKD Stage & Risk Calculator

Enter the patient's latest values to calculate KDIGO combined GFR/albuminuria risk category, recommended monitoring schedule, and any urgent action flags.

Blood Pressure Monitoring — Best Practice
💊 BP Targets in CKD
  • All CKD: <130/80 mmHg (KDIGO 2021)
  • CKD with diabetes: <130/80 (some guidelines <120 systolic if tolerated)
  • Proteinuric CKD: stricter control reduces ACR and slows progression
  • Elderly/frail: individualise — avoid orthostatic hypotension
📏 BP Measurement Tips
  • Patient seated quietly 5 min before measurement
  • No caffeine, smoking, or exercise 30 min prior
  • Correct cuff size — arm circumference dictates cuff width
  • Do NOT take BP on the AV fistula arm
  • ABPM preferred: 24-hour recording, validates white-coat and masked hypertension
  • Home BP: validated device, correct technique, log readings
Anaemia of CKD
🩸 Pathophysiology & Diagnosis

Anaemia of CKD is predominantly due to reduced EPO production by the diseased kidney. Contributing factors: iron deficiency (most common), chronic inflammation, shortened red cell survival, blood loss from dialysis.

  • Investigate anaemia at eGFR <60 — exclude other causes first (B12, folate, haemolysis, blood loss)
  • Iron studies: ferritin, TSAT — treat iron deficiency before/alongside EPO
  • IV iron (ferric carboxymaltose or iron sucrose) — more effective than oral in CKD G4+
  • Target Hb: 100–120 g/L on ESA therapy; avoid >130 g/L (thrombosis risk)
💉 ESA & Iron Therapy
  • Erythropoietin (EPO) — epoetin alfa/beta SC injection, typically 2–3x weekly
  • Darbepoetin alfa — longer-acting, once weekly or fortnightly SC
  • Nurse role: teach self-injection technique, rotate sites (abdomen, thigh), sharps disposal
  • Monitor BP — ESA can increase BP; check at each visit
  • IV ferric carboxymaltose — given in renal clinic over 15 min; observe for infusion reactions
  • Document iron levels before each ESA dose — do NOT give ESA if ferritin <100 or TSAT <20%
Renal Bone-Mineral Disease (CKD-MBD)
🦴 Phosphate, Calcium, PTH & Vitamin D
Secondary hyperparathyroidism begins from G3b. Elevated PTH drives bone disease, vascular calcification, and cardiac risk. Early intervention with phosphate binders and active Vitamin D is critical.

Phosphate Binders — Timing is Everything

  • MUST be taken WITH food — not before, not after; bind dietary phosphate in the gut
  • Calcium carbonate (Calcichew) — first line; cheap; avoid if hypercalcaemia
  • Sevelamer carbonate (Renvela) — non-calcium binder; preferred if calcification risk
  • Lanthanum carbonate (Fosrenol) — chewable tablet; effective; expensive
  • Educate: take with EVERY meal and snack containing protein

Active Vitamin D & Calcimimetics

  • Alfacalcidol (1-alpha hydroxyvitamin D) — active form, does not require renal activation; for secondary hyperparathyroidism
  • Calcitriol — active Vit D; alternative
  • Cinacalcet (Mimpara) — calcimimetic; reduces PTH secretion; take with food; watch for hypocalcaemia and nausea
  • Native Vit D (cholecalciferol) — replenish if 25-OH Vit D <50 nmol/L before using active forms
Metabolic Acidosis
⚗️ Bicarbonate Supplementation

Metabolic acidosis accelerates CKD progression (activates complement, increases protein catabolism, promotes bone resorption). Target serum bicarbonate >22 mmol/L.

Hyperkalaemia Management
Potassium Binders & Dietary Management
K+ >6.0 mmol/L = urgent review. K+ >6.5 with ECG changes = emergency. Contact prescriber immediately. Withhold ACEi/ARB temporarily.

Dietary Restriction

  • Restrict high-potassium foods: potatoes, tomatoes, bananas, oranges, dates (critical in GCC), dried fruit, nuts, chocolate, coffee
  • Leaching vegetables: peel, dice small, boil in large volume of water, discard water
  • Avoid potassium-containing salt substitutes (LoSalt etc.)
  • Refer to renal dietitian for personalised plan

Potassium Binders (Newer Agents)

  • Patiromer (Veltassa) — non-absorbed polymer; once daily with food; onset 7–48 hours; avoid within 3 hours of other meds
  • Sodium zirconium cyclosilicate (Lokelma) — highly selective; rapid onset (~1 hour); 10 g three times daily initially then maintenance; give on empty stomach
  • Traditional: calcium resonium — less preferred; constipation risk
  • Monitor K+ within 1 week of starting binders; adjust dose
Complications Monitoring Checklist
Renal Dietitian — Central Role
🥗 Dietitian Referral & Role

All patients with CKD G3b or higher should have access to a specialist renal dietitian. Dietary advice in CKD is complex, individualised, and evolves with disease stage. Nurse specialists should reinforce key principles but refer to dietitian for detailed plans.

Dietary restriction should be evidence-based and individualised — over-restriction of protein and potassium in early CKD can worsen malnutrition. Prescriptive restrictions without dietitian input may cause harm.
Dietary Modifications by CKD Stage
CKD StageProteinPhosphatePotassiumSodiumFluid
G1–G2 Normal intake; avoid high-protein diets Reduce processed food additives No restriction unless K+ elevated <6 g/day NaCl Well hydrated — 1.5–2 L/day
G3 0.8 g/kg/day; reduce red meat Avoid phosphate additives; start monitoring Monitor; restrict if ACR elevated <5 g/day NaCl Maintain good hydration
G4 0.6–0.8 g/kg/day with dietitian Restrict — <800 mg/day; binders with food Restrict if K+ >5.5 — <2 g/day K+ <5 g/day NaCl; fluid watch 1.5–2 L/day unless oedema
G5 pre-dialysis 0.6 g/kg/day; adequate calorie intake essential Strict restriction; binders mandatory Strict restriction + binders Strict <4–5 g NaCl May restrict if anuric/oliguric
GCC-Specific Dietary Challenges
🫓 High-Phosphate Foods Common in GCC Diet
  • Arabic/unleavened bread (khubz) — moderate phosphate, consumed in large quantities
  • Dairy products — laban, labneh, cheese, milk — high phosphate
  • Red meat & grilled lamb — frequent in traditional meals
  • Processed foods & fast food — phosphate additives highly bioavailable (>organic phosphate)
  • Cola drinks — high phosphoric acid; advise complete avoidance in G4+
  • Nuts — almonds, pistachios (common snack) — high phosphate and potassium
🍌 High-Potassium Staples in GCC Diet
  • Dates (tamr) — culturally very significant; extremely high potassium; must counsel carefully — 2–3 dates only if K+ stable
  • Tomatoes — widely used in cooking; high K+; leach or reduce quantities
  • Bananas, mangoes — tropical fruits common in region
  • Potatoes — integral to many GCC dishes; leach to reduce K+
  • Dried fruits & concentrated juices — high K+; avoid in G4+
  • Coconut water — very high K+; advise avoidance completely
Ramadan Fasting & CKD
🌙 Ramadan Counselling for CKD Patients
CKD patients should be assessed individually regarding safety to fast. Those with G4–G5 or unstable electrolytes should be counselled that fasting may be contraindicated — seek religious scholar consultation alongside medical advice.
  • Discuss with nephrologist and dietitian before Ramadan begins
  • Medicines requiring even dosing intervals may need restructuring (e.g. phosphate binders 3x daily → with Iftar, Suhoor, large snack)
  • Fluid restriction challenge — all fluid intake concentrated into non-fasting hours
  • Increased protein at Iftar (meat, lentils) — may worsen hyperkalaemia and phosphate load
  • BP medications timing — adjust to evening/Suhoor dosing
  • Avoid large carbohydrate loads at Iftar (glycaemic spike in diabetic CKD)
  • Monitor BP and bloods more frequently during Ramadan (eGFR, K+, bicarb)
  • AKI risk from dehydration — educate on warning signs: decreased urine, dizziness, nausea
  • Encourage Suhoor (pre-dawn meal) — spreads nutrition and reduces fasting duration effectively
Fluid Management
💧 Fluid Guidance by Stage

Fluid restriction is NOT required in early CKD (G1–G4). Adequate hydration is beneficial and reduces AKI risk. Restriction is typically introduced only at G5 when urine output is significantly reduced or on dialysis.

In GCC summer (ambient temperature 40–48°C), outdoor workers and active patients lose significant fluid via sweat. Fluid intake guidance must account for environmental conditions.
Diet Counselling Checklist
When to Start RRT Discussions
🗓️ Early Planning Reduces Crisis Starts
Begin RRT modality education from CKD G4 (eGFR 15–29). Patients who start dialysis as an emergency (without planned access) have significantly worse outcomes. The goal is a planned, informed start with functioning access in place.

KDIGO recommends that RRT timing be based on symptoms and functional status, not eGFR alone. Typical initiation: eGFR 5–10 with uraemic symptoms, fluid overload, severe electrolyte disturbance, or malnutrition.

RRT Modality Choice — Shared Decision Making
🏥 Haemodialysis (HD)
  • 3x weekly, typically 4 hours each session
  • In-centre or home HD
  • Access: AV fistula (preferred), AV graft, tunnelled CVC
  • Suits patients with: strong social support, inability to do self-care, travel frequently
  • Challenges: travel to centre 3x/week, strict fluid/diet adherence between sessions
🏠 Peritoneal Dialysis (PD)
  • Daily, home-based — CAPD or APD (overnight machine)
  • Access: Tenckhoff peritoneal catheter (surgical insertion)
  • Suits patients with: independent patients, working patients, those wishing to maintain normal daily routine
  • PD first approach recommended in GCC — less cardiovascular stress, preserves residual renal function longer
  • Training: 1–2 weeks of PD training before commencing
🫀 Kidney Transplant
  • Best long-term outcome of all RRT options — 10-year survival significantly better than dialysis
  • List early: refer from eGFR 20 for live donor pathway — pre-emptive transplant possible
  • Deceased donor waitlist: years-long in many GCC countries
  • Living donation dominant in GCC — family evaluation, ethics review, medical assessment
  • Contraindications: active malignancy, uncontrolled infection, severe cardiac disease
AV Fistula — Planning & Protection
💪 AV Fistula Creation & Care
Once AV fistula planning begins — NO BP measurements, blood sampling, IV cannulas, or tourniquets on the fistula arm. Document in patient notes prominently. Educate patient to inform ALL healthcare providers.

Referral Timing

  • Refer to vascular surgery when eGFR 15–20 mL/min
  • Allow 3–6 months for maturation before first needling
  • Radiocephalic (wrist) fistula preferred; brachiocephalic if wrist vessels inadequate
  • Fistula mapping ultrasound before surgery to assess vessel suitability

Fistula Maturation & Exercises

  • Encourage fistula exercises: repeatedly squeezing a soft ball 10 min, 3x daily
  • Assess maturity: thrill on palpation, bruit on auscultation, visible/palpable vessel
  • Dialysis unit will check: flow >600 mL/min, diameter >6 mm, depth <6 mm for needling
  • Patient education: feel for thrill daily — report any loss, pain, swelling, discharge
Peritoneal Dialysis Catheter (Tenckhoff)
🔗 Tenckhoff Catheter Planning
Pre-emptive Transplant & Waitlist
Best Outcomes with Pre-emptive Transplant

Pre-emptive transplant (transplant before starting dialysis) has the best patient and graft survival of all RRT strategies. In GCC, living donor transplants are most common — family members can donate voluntarily following ethical and medical evaluation.

Conservative Kidney Management (CKM)
🕊️ CKM — For Elderly or Frail Patients

Conservative kidney management (not starting dialysis) is a valid, patient-centred choice — particularly for elderly frail patients with significant comorbidities where dialysis may not improve quality of life or survival. This is NOT giving up — it is active symptom management.

  • Symptom management: pruritus (antihistamines, gabapentin, naltrexone), pain, nausea, oedema (diuretics)
  • Psychosocial and spiritual support
  • Advance care planning: preferred place of death, resuscitation wishes, lasting power of attorney
  • Palliative care team involvement
  • Research shows: CKM vs HD in frail elderly patients >75 — survival difference is smaller than expected, and quality of life may be better with CKM
  • Document decision clearly in notes — involves patient, family, nephrologist, palliative care
  • In GCC: cultural and family factors central — family counselling often required; religious guidance that refusing treatment is not sinful
RRT Preparation Checklist
GCC ESRD — Causes & Epidemiology
🌡️ Dominant ESRD Causes in GCC
  • Diabetic nephropathy — overwhelmingly the leading cause; T2DM prevalence 15–25% in GCC adult nationals
  • Hypertensive nephrosclerosis — closely linked to DM; often both diagnoses co-exist
  • IgA nephropathy & FSGS — more prominent in younger patients
  • Lupus nephritis — female predominance; seen in GCC populations
  • Genetic causes — higher prevalence of consanguineous marriages in GCC → Alport syndrome, polycystic kidney disease, hereditary FSGS
  • Obstructive uropathy — renal stones common due to heat + dehydration; if undetected → CKD
👷 CKD of Uncertain Aetiology — Migrant Workers
An emerging concern in GCC: outdoor migrant workers (construction, agriculture, service industry) exposed to extreme heat show higher rates of CKD without classical risk factors — similar to the Mesoamerican nephropathy pattern seen in Central American sugarcane workers.
  • Mechanism: recurrent heat-associated AKI → cumulative kidney injury → CKD
  • No hypertension, no diabetes — tubular pattern of injury
  • Described in outdoor workers in UAE, Qatar, Saudi Arabia
  • Prevention: workplace heat protection, mandatory hydration breaks, health surveillance
  • Nurse role: take occupational history in young male workers with unexplained CKD
GCC Renal Services
CountryDialysis Population (approx.)Key CentresTransplant Programme
Saudi Arabia>18,000 HD patients (largest in GCC)King Abdulaziz Medical City, King Faisal Specialist Hospital, King Salman HospitalWell established — SCOT coordinates deceased + living donor; longest-running programme in region
UAERapidly growing; multiple Emirates centresSheikh Khalifa Hospital Abu Dhabi, Rashid Hospital Dubai, Cleveland Clinic Abu DhabiFederal Transplant Law 2016; living donation established; deceased donor growing
Qatar~1,500 HD patientsHamad Medical Corporation — Hamad NephrologyLiving donor; deceased donor growing
Kuwait~2,000 HD patientsMubarak Al-Kabeer HospitalLiving and deceased donor programme
Bahrain~600 HD patientsSalmaniya Medical ComplexLiving donor; small deceased donor programme
Oman~1,800 HD patientsRoyal Hospital Muscat, Sultan Qaboos University HospitalLiving and deceased donor; strong primary care CKD detection
Home Dialysis in GCC
🏡 Peritoneal Dialysis Growth
  • Home PD programmes growing across all GCC countries
  • APD (automated PD) machines allow overnight dialysis with freedom during day
  • Advantages for GCC: avoids frequent clinic travel, suited to family-centred home culture
  • Challenges: training family members, maintaining sterile supplies, limited community nurse visit infrastructure
  • GCC goal: 20–30% of dialysis patients on PD (currently <15% in most countries)
🏥 Home Haemodialysis Pilots
  • Home HD pilot programmes in UAE and Saudi Arabia — early stage
  • Advantages: more frequent shorter sessions → better cardiovascular outcomes, dietary freedom
  • Challenges: capital cost of machines, water supply installation, training requirements, support infrastructure
  • Growing evidence supports nocturnal home HD (6 nights/week, 6–8 hours) as superior to conventional HD
Renal Nutrition & Psychosocial Support in GCC
🥙 Renal Nutrition Services
  • Community renal dietitian services limited in most GCC countries — hospital-based
  • Arabic-language dietary resources for CKD patients are scarce — translation gap
  • Traditional GCC diet — high in phosphate, potassium, sodium — significant dietary education burden
  • Halal considerations: all first-line phosphate binders and ESA are permissible; some medications use gelatin capsules — check and advise patients to verify
  • Need for culturally-adapted renal diet materials in Arabic, Urdu, Tagalog, Hindi (for migrant populations)
🤝 Peer Support & Psychology
  • Formal CKD peer support groups limited in GCC — online Arabic-language groups emerging
  • Family involvement critical in GCC culture — family as primary support network
  • Depression and anxiety common in CKD — often underdiagnosed; stigma around mental health remains barrier
  • Nurse specialists can: screen for depression (PHQ-9), provide brief psychoeducation, refer to renal social worker or psychologist
  • Islamic spiritual care: chaplaincy services at major hospitals; patients often find faith supports coping
Kidney Transplant — Living Donation in GCC
💙 Living Donation Landscape

Living donation is the dominant pathway in GCC due to limited deceased donor programmes. Cultural and religious factors generally support altruistic family donation. Key points for nursing practice:

  • Donor evaluation includes: full medical assessment, renal function, surgical risk, psychosocial assessment
  • Donor must be fully informed, voluntary, and have no financial incentive (organ trafficking prohibited)
  • Saudi SCOT: well-established framework for living and deceased donor allocation
  • UAE: Federal Law No. 5 (2016) on organ transplantation — comprehensive framework
  • Post-transplant nurse role: immunosuppression adherence education (tacrolimus, MMF, prednisolone), infection prophylaxis, rejection surveillance
  • Tacrolimus levels — narrow therapeutic window; check troughs; drug interactions (azithromycin, antifungals)
  • Skin cancer and PTLD screening — post-transplant malignancy risk
  • Deceased donor programmes developing: opt-in consent model in most GCC countries
GCC Context Nursing Checklist